Search results (14)
« Back to PublicationsStructural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR
Preprint
Williams BG. et al, (2025)
Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR
Preprint
Williams BG. et al, (2025)
Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.
Preprint
Guerra N. et al, (2025)
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Journal article
Barrett JR. et al, (2024), Cell, 187, 4964 - 4980.e21
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
Journal article
King LDW. et al, (2024), Cell Rep Med, 5
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Journal article
Williams BG. et al, (2024), Nat Commun, 15
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Preprint
Williams BG. et al, (2024)
Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
Preprint
King LDW. et al, (2024)
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.
Journal article
Weiss GE. et al, (2023), PLoS Pathog, 19
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
Journal article
Alanine DGW. et al, (2019), Cell, 178, 216 - 228.e21
Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of Staphylococcus aureus.
Journal article
Laabei M. et al, (2015), PLoS Biol, 13
FGT-1 is the major glucose transporter in C. elegans and is central to aging pathways.
Journal article
Feng Y. et al, (2013), Biochem J, 456, 219 - 229